1.
Chinese Journal of Gastroenterology
;
(12): 52-56, 2022.
Artigo
em Chinês
| WPRIM
| ID: wpr-1016148
RESUMO
Ulcerative colitis (UC) is a chronic immune-mediated gastrointestinal inflammatory disease, the etiology has not been fully clarified. As a developing and emerging industrialized country, China is about to enter or has entered the stage of ' accelerated incidence rate and compound epidemic' of UC. Evaluate the clinical condition of refractory ulcerative colitis (RUC) at its early stage and select appropriate treatment is important. Although the kinds of drug become more and more, the rate of colon resection remains unchanged. When drug therapy cannot improve the symptoms of patient, surgical treatment should be considered. This article reviewed the progress in studies on diagnosis and surgical treatment of RUC.